Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care

被引:24
|
作者
Taylor, Jacob [1 ,2 ]
Anderson, William S. [3 ]
Brandt, Jason [4 ]
Mari, Zoltan [5 ]
Pontone, Gregory M. [4 ]
机构
[1] Brigham & Womens Hosp, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA
[2] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA
[3] Johns Hopkins Univ Hosp, Dept Neurosurg, Baltimore, MD 21287 USA
[4] Johns Hopkins Univ Hosp, Dept Psychiat & Behav Sci, Phipps Suite 300,1800 Orleans St, Baltimore, MD 21287 USA
[5] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA
来源
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2016年 / 24卷 / 12期
基金
美国国家卫生研究院;
关键词
parkinson disease; multidisciplinary care; neuropsychiatric (symptoms); nonmotor (symptoms); dopamine replacement therapy (DRT); depression; anxiety; IMPULSE CONTROL DISORDERS; DOPAMINE DYSREGULATION SYNDROME; DRUG-INDUCED PSYCHOSIS; QUALITY-OF-LIFE; REPLACEMENT THERAPY; NONMOTOR SYMPTOMS; UPDATE TREATMENTS; ANXIETY; PREVALENCE; DEPRESSION;
D O I
10.1016/j.jagp.2016.08.017
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Although Parkinson disease (PD) is defined clinically by its motor symptoms, it is increasingly recognized that much of the disability and worsened quality of life experienced by patients with PD is attributable to psychiatric symptoms. The authors describe a model of multidisciplinary care that enables these symptoms to be effectively managed. They describe neuropsychiatric complications of PD itself and pharmacologic and neurostimulation treatments for parkinsonian motor symptoms and discuss the management of these complications. Specifically, they describe the clinical associations between motor fluctuations and anxiety and depressive symptoms, the compulsive overuse of dopaminergic medications prescribed for motor symptoms (the dopamine dysregulation syndrome), and neuropsychiatric complications of these medications, including impulse control disorders, psychosis, and manic syndromes. Optimal management of these problems requires close collaboration across disciplines because of the potential for interactions among the pathophysiologic process of PD, motor symptoms, dopaminergic drugs, and psychiatric symptoms. The authors emphasize how their model of multidisciplinary care facilitates close collaboration among psychiatrists, other mental health professionals, neurologists, and functional neurosurgeons and how this facilitates effective care for patients who develop the specific neuropsychiatric complications discussed.
引用
收藏
页码:1171 / 1180
页数:10
相关论文
共 50 条
  • [1] Neuropsychiatric Treatments for Parkinson's Disease: Nonpharmacological Approaches
    Mathur, Neha
    Bhatt, Haseel
    Lidstone, Sarah C.
    SEMINARS IN NEUROLOGY, 2022, 42 (02) : 158 - 167
  • [2] Neuropsychiatric Symptoms in Parkinson's Disease
    Aarsland, Dag
    Kramberger, Milica Gregoric
    JOURNAL OF PARKINSONS DISEASE, 2015, 5 (03) : 659 - 667
  • [3] Neuropsychiatric aspects of Parkinson's disease
    Nagy, Anna
    Schrag, Anette
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (07) : 889 - 896
  • [4] Drug treatments for the neuropsychiatric complications of Parkinson's disease
    Connolly, Barbara S.
    Fox, Susan H.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (12) : 1439 - 1449
  • [5] Recognition and treatment of neuropsychiatric disturbances in Parkinson's disease
    Akbar, Umer
    Friedman, Joseph H.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (09) : 1053 - 1065
  • [6] Neuropsychiatric aspects of Parkinson’s disease
    Anna Nagy
    Anette Schrag
    Journal of Neural Transmission, 2019, 126 : 889 - 896
  • [7] Neuropsychiatric Issues in Parkinson's Disease
    Cooney, Jeffrey W.
    Stacy, Mark
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (05)
  • [8] Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease
    Balestrino, Roberta
    Martinez-Martin, Pablo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 373 : 173 - 178
  • [9] Neuropsychiatric characteristics of GBA-associated Parkinson disease
    Swan, Matthew
    Doan, Nancy
    Ortega, Robert A.
    Barrett, Matthew
    Nichols, William
    Ozelius, Laurie
    Soto-Valencia, Jeannie
    Boschung, Sarah
    Deik, Andres
    Sarva, Harini
    Cabassa, Jose
    Johannes, Brooke
    Raymond, Deborah
    Marder, Karen
    Giladi, Nir
    Miravite, Joan
    Severt, William
    Sachdev, Rivka
    Shanker, Vicki
    Bressman, Susan
    Saunders-Pullman, Rachel
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 370 : 63 - 69
  • [10] Symptom dimensions of anxiety in Parkinson's disease: Replication study in a neuropsychiatric patient population
    Rutten, Sonja
    van Wegen, Erwin E. H.
    Ghielen, Ires
    Schoon, Bridget
    van den Heuvel, Odile A.
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2021, 5